Infinity Stock Buy Hold or Sell Recommendation

INFI -  USA Stock  

USD 1.11  0.07  5.93%

Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Infinity Pharmaceuti is 'Cautious Hold'. Macroaxis provides Infinity Pharmaceuti buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding INFI positions. The advice algorithm takes into account all of Infinity Pharmaceuti's available fundamental, technical, and predictive indicators you will find on this site.

Infinity Advice 

 
Refresh
The advice is provided from Infinity Pharmaceuti's buy-and-hold perspective. Please see Infinity Pharmaceuti Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Infinity and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Infinity Pharmaceuti.

Execute Infinity Pharmaceuti Buy or Sell Advice

The Infinity recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Infinity Pharmaceuti. Macroaxis does not own or have any residual interests in Infinity Pharmaceuti or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Infinity Pharmaceuti's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Infinity PharmaceutiBuy Infinity Pharmaceuti
Cautious Hold

Volatility

Very riskyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very LowDetails

Economic Sensitivity

Actively responds to the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Infinity Pharmaceuti has a Mean Deviation of 3.69, Standard Deviation of 5.08 and Variance of 25.77
We provide advice to complement the regular expert consensus on Infinity Pharmaceuti. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Infinity Pharmaceuti is not overpriced, please check out all Infinity Pharmaceuti fundamentals, including its number of shares shorted, cash and equivalents, earnings per share, as well as the relationship between the revenue and current ratio . Given that Infinity Pharmaceuti is a hitting penny stock territory we urge to closely look at its price to book.

Infinity Pharmaceuti Trading Alerts and Improvement Suggestions

Infinity Pharmaceuti generated a negative expected return over the last 90 days
Infinity Pharmaceuti has high historical volatility and very poor performance
Infinity Pharmaceuti may become a speculative penny stock
Infinity Pharmaceuti was previously known as Infinity Pharmaceuticals and was traded on NASDAQ Exchange under the symbol DPII.
The company reported the previous year's revenue of 1.84 M. Net Loss for the year was (44.21 M) with loss before overhead, payroll, taxes, and interest of (26.08 M).
Infinity Pharmaceuti currently holds about 90.09 M in cash with (39.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.
Infinity Pharmaceuti has a frail financial position based on the latest SEC disclosures
Roughly 59.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Ilaria Robert Jr of 87472 shares of Infinity Pharmaceuti subject to Rule 16b-3

Infinity Pharmaceuti current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Infinity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Infinity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price10.00
Target Median Price9.00
Target High Price14.00
Recommendation Mean1.90
Number Of Analyst Opinions8
Target Low Price7.00
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Infinity Pharmaceuti Returns Distribution Density

The distribution of Infinity Pharmaceuti's historical returns is an attempt to chart the future uncertainty of Infinity Pharmaceuti's future price movements. The chart of the probability distribution of Infinity Pharmaceuti stock daily returns describes the distribution of returns around its average expected value. We use Infinity Pharmaceuti price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Infinity Pharmaceuti returns is essential to provide solid investment advice for Infinity Pharmaceuti stock.
Mean Return-1.05Value At Risk-9.58
Potential Upside6.67Standard Deviation5.08
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Infinity Pharmaceuti historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Infinity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Infinity Pharmaceuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Infinity Pharmaceuti backward and forwards among themselves. Infinity Pharmaceuti's institutional investor refers to the entity that pools money to purchase Infinity Pharmaceuti's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Callan Capital LlcCommon Shares146.2 K329 K
Russell Investments Group LtdCommon Shares37.9 K85 K
Cutler Group LpCommon Shares9.3 K20 K
National Bank Of CanadaCommon Shares2.6 KK
Koshinski Asset Management IncCommon SharesK4.5 K
Cutler Group LpPut Options7001000
Cutler Group LpCall Options3000.0
Tci Wealth Advisors IncCommon Shares2000.0
Bvf IncCommon Shares8.4 M28.7 M
Note, although Infinity Pharmaceuti's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Infinity Pharmaceuti Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure1.48 M707 K(2.33 M)(43 K)(49.45 K)(53.35 K)
Depreciation Amortization and Accretion1.72 M191 K219 K483 K434.7 K446.14 K
Net Cash Flow or Change in Cash and Cash Equivalents(41.13 M)14.01 M(26.04 M)6.33 M5.7 M6.15 M
Issuance Purchase of Equity Shares146 K9.62 M112 K7.87 M7.08 M7.27 M
Net Cash Flow from Financing(146 K)5.62 M27.73 M27.44 M24.7 M30.54 M
Net Cash Flow from Investing(4.28 M)13.1 M(12.24 M)14.63 M16.83 M18.15 M
Net Cash Flow Investment Acquisitions and Disposals(4.99 M)13.1 M(9.91 M)14.67 M16.88 M18.21 M
Net Cash Flow from Operations(36.71 M)(4.71 M)(41.53 M)(35.74 M)(41.1 M)(44.34 M)
Share Based Compensation6.97 M3.45 M2.13 M1.46 M1.31 M1.34 M

Infinity Pharmaceuti Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Infinity Pharmaceuti or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Infinity Pharmaceuti stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Infinity stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.93
β
Beta against DOW1.85
σ
Overall volatility
5.21
Ir
Information ratio -0.2

Infinity Pharmaceuti Volatility Alert

Infinity Pharmaceuti exhibits very low volatility with skewness of -0.23 and kurtosis of 1.84. However, we advise investors to further study Infinity Pharmaceuti technical indicators to make sure all market info is available and is reliable. Infinity Pharmaceuti is a potential penny stock. Although Infinity Pharmaceuti may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Infinity Pharmaceuti. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Infinity instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Infinity Pharmaceuti Fundamentals Vs Peers

Comparing Infinity Pharmaceuti's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Infinity Pharmaceuti's direct or indirect competition across all of the common fundamentals between Infinity Pharmaceuti and the related equities. This way, we can detect undervalued stocks with similar characteristics as Infinity Pharmaceuti or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Infinity Pharmaceuti's fundamental indicators could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuti by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Infinity Pharmaceuti to competition
FundamentalsInfinity PharmaceutiPeer Average
Return On Equity(490.76) %(0.31) %
Return On Asset(38.68) %(0.14) %
Current Valuation104.23 M16.62 B
Shares Outstanding89.02 M571.82 M
Shares Owned by Insiders2.17 %10.09 %
Shares Owned by Institutions58.68 %39.21 %
Number of Shares Shorted2.74 M4.71 M
Price to Earning(1.63) X28.72 X
Price to Book3.27 X9.51 X
Price to Sales56.99 X11.42 X
Revenue1.84 M9.43 B
Gross Profit(26.08 M)27.38 B
EBITDA(43.34 M)3.9 B
Net Income(44.21 M)570.98 M
Cash and Equivalents90.09 M2.7 B
Cash per Share1.01 X5.01 X
Total Debt1.6 M5.32 B
Debt to Equity0.049 %48.70 %
Current Ratio7.44 X2.16 X
Book Value Per Share0.36 X1.93 K
Cash Flow from Operations(39.41 M)971.22 M
Short Ratio1.43 X4.00 X
Earnings Per Share(0.56) X3.12 X
Price to Earnings To Growth(0.05) X4.89 X
Number of Employees2318.84 K
Beta1.96-0.15
Market Capitalization105.04 M19.03 B
Total Asset288.82 M29.47 B
Retained Earnings(783.13 M)9.33 B
Working Capital184.64 M1.48 B
Current Asset254.7 M9.34 B
Current Liabilities70.06 M7.9 B
Z Score36.28.72
   Acquisition by Ilaria Robert Jr of 87472 shares of Infinity Pharmaceuti subject to Rule 16b-3 [view details]

Infinity Pharmaceuti Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Infinity . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution67686.39
Daily Balance Of Power(0.58)
Rate Of Daily Change0.94
Day Median Price1.16
Day Typical Price1.14
Price Action Indicator(0.09)

About Infinity Pharmaceuti Buy or Sell Advice

When is the right time to buy or sell Infinity Pharmaceuti? Buying financial instruments such as Infinity Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Infinity Pharmaceuti investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Accounts Payable3.43 M3.98 M
Receivables1.07 M856.73 K

Use Investing Ideas to Build Portfolios

In addition to having Infinity Pharmaceuti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Printing and Publishing Thematic Idea Now

Printing and Publishing
Printing and Publishing Theme
Fama and French focuses on testing asset pricing under different economic assumptions. Printing and Publishing theme has 46 constituents.
View All  Next Launch Printing and Publishing
Please see Infinity Pharmaceuti Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.